APO Research
Talk to an analyst

APO RESEARCH · REPORT

Betahistine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Betahistine Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchBetahistine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Betahistine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Betahistine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Betahistine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Betahistine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Betahistine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Betahistine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Betahistine market include TOWA PHARMACEUTICAL CO., LTD, Takeda Pharmaceutical Company Limited, Mylan, Orion Corporation, Nichi-Iko Pharmaceutical, HENNIG ARZNEIMITTEL GmbH & Co. KG, EA Pharma Co., Ltd., DOC Generici and Disphar International B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Betahistine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Betahistine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Betahistine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Betahistine market size, projected growth trends, production technologies, key applications, and end-use industries.

Betahistine Segment by Company

TOWA PHARMACEUTICAL CO., LTD

Takeda Pharmaceutical Company Limited

Mylan

Orion Corporation

Nichi-Iko Pharmaceutical

HENNIG ARZNEIMITTEL GmbH & Co. KG

EA Pharma Co., Ltd.

DOC Generici

Disphar International B.V.

Ciclum Farma Unipessoal

Betahistine Segment by Type

8mg

25mg

Others

Betahistine Segment by Application

Cerebral Thrombosis

Cerebral Embolism

Others

Betahistine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Betahistine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Betahistine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Betahistine significant trends, drivers, influence factors in global and regions.

6. To analyze Betahistine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Betahistine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Betahistine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Betahistine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Betahistine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Betahistine industry.

Chapter 3: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Betahistine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Betahistine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Betahistine Industry Trends Table 2. Betahistine Industry Drivers Table 3. Betahistine Industry Opportunities and Challenges Table 4. Betahistine Industry Restraints Table 5. Global Betahistine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Betahistine Revenue Share by Company (2021-2026) Table 7. Global Betahistine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Betahistine Sales Volume Share by Company (2021-2026) Table 9. Global Betahistine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Betahistine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Betahistine Key Company Manufacturing Base & Headquarters Table 12. Global Betahistine Company, Product Type & Application Table 13. Global Betahistine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Betahistine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 8mg Table 18. Significant Companies of 25mg Table 19. Significant Companies of Others Table 20. Global Betahistine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Betahistine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Betahistine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Betahistine Sales Volume Share by Type (2021-2026) Table 24. Global Betahistine Sales Volume Share by Type (2027-2032) Table 25. Global Betahistine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Betahistine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Betahistine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Betahistine Sales Value Share by Type (2021-2026) Table 29. Global Betahistine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cerebral Thrombosis Table 31. Significant Companies of Cerebral Embolism Table 32. Significant Companies of Others Table 33. Global Betahistine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Betahistine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Betahistine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Betahistine Sales Volume Share by Application (2021-2026) Table 37. Global Betahistine Sales Volume Share by Application (2027-2032) Table 38. Global Betahistine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Betahistine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Betahistine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Betahistine Sales Value Share by Application (2021-2026) Table 42. Global Betahistine Sales Value Share by Application (2027-2032) Table 43. Global Betahistine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Betahistine Sales by Region (2021-2026) & (K Units) Table 45. Global Betahistine Sales Market Share by Region (2021-2026) Table 46. Global Betahistine Sales by Region (2027-2032) & (K Units) Table 47. Global Betahistine Sales Market Share by Region (2027-2032) Table 48. Global Betahistine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Betahistine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Betahistine Sales Value Share by Region (2021-2026) Table 51. Global Betahistine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Betahistine Sales Value Share by Region (2027-2032) Table 53. Global Betahistine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Betahistine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Betahistine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Betahistine Sales by Country (2021-2026) & (K Units) Table 58. Global Betahistine Sales Market Share by Country (2021-2026) Table 59. Global Betahistine Sales by Country (2027-2032) & (K Units) Table 60. Global Betahistine Sales Market Share by Country (2027-2032) Table 61. Global Betahistine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Betahistine Sales Value Market Share by Country (2021-2026) Table 63. Global Betahistine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Betahistine Sales Value Market Share by Country (2027-2032) Table 65. TOWA PHARMACEUTICAL CO., LTD Company Information Table 66. TOWA PHARMACEUTICAL CO., LTD Business Overview Table 67. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio Table 69. TOWA PHARMACEUTICAL CO., LTD Recent Development Table 70. Takeda Pharmaceutical Company Limited Company Information Table 71. Takeda Pharmaceutical Company Limited Business Overview Table 72. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Takeda Pharmaceutical Company Limited Betahistine Product Portfolio Table 74. Takeda Pharmaceutical Company Limited Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Mylan Betahistine Product Portfolio Table 79. Mylan Recent Development Table 80. Orion Corporation Company Information Table 81. Orion Corporation Business Overview Table 82. Orion Corporation Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Orion Corporation Betahistine Product Portfolio Table 84. Orion Corporation Recent Development Table 85. Nichi-Iko Pharmaceutical Company Information Table 86. Nichi-Iko Pharmaceutical Business Overview Table 87. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Nichi-Iko Pharmaceutical Betahistine Product Portfolio Table 89. Nichi-Iko Pharmaceutical Recent Development Table 90. HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information Table 91. HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview Table 92. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio Table 94. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development Table 95. EA Pharma Co., Ltd. Company Information Table 96. EA Pharma Co., Ltd. Business Overview Table 97. EA Pharma Co., Ltd. Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. EA Pharma Co., Ltd. Betahistine Product Portfolio Table 99. EA Pharma Co., Ltd. Recent Development Table 100. DOC Generici Company Information Table 101. DOC Generici Business Overview Table 102. DOC Generici Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. DOC Generici Betahistine Product Portfolio Table 104. DOC Generici Recent Development Table 105. Disphar International B.V. Company Information Table 106. Disphar International B.V. Business Overview Table 107. Disphar International B.V. Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Disphar International B.V. Betahistine Product Portfolio Table 109. Disphar International B.V. Recent Development Table 110. Ciclum Farma Unipessoal Company Information Table 111. Ciclum Farma Unipessoal Business Overview Table 112. Ciclum Farma Unipessoal Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Ciclum Farma Unipessoal Betahistine Product Portfolio Table 114. Ciclum Farma Unipessoal Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Betahistine Distributors List Table 118. Betahistine Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Betahistine Product Image Figure 2. Global Betahistine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Betahistine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Betahistine Sales (2021-2032) & (K Units) Figure 5. Global Betahistine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Betahistine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 8mg Image Figure 10. 25mg Image Figure 11. Others Image Figure 12. Global Betahistine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Betahistine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Betahistine Sales Volume Share by Type (2021-2032) Figure 15. Global Betahistine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Betahistine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Betahistine Sales Value Share by Type (2021-2032) Figure 18. Cerebral Thrombosis Image Figure 19. Cerebral Embolism Image Figure 20. Others Image Figure 21. Global Betahistine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Betahistine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Betahistine Sales Volume Share by Application (2021-2032) Figure 24. Global Betahistine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Betahistine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Betahistine Sales Value Share by Application (2021-2032) Figure 27. Global Betahistine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Betahistine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Betahistine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Betahistine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Betahistine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Betahistine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Betahistine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Betahistine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Betahistine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Betahistine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Betahistine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Betahistine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Betahistine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Betahistine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Betahistine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Betahistine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Betahistine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Betahistine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Betahistine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg
  • 25mg
  • Others
Applications
  • Cerebral Thrombosis
  • Cerebral Embolism
  • Others
Companies covered
  • TOWA PHARMACEUTICAL CO., LTD
  • Takeda Pharmaceutical Company Limited
  • Mylan
  • Orion Corporation
  • Nichi-Iko Pharmaceutical
  • HENNIG ARZNEIMITTEL GmbH & Co. KG
  • EA Pharma Co., Ltd.
  • DOC Generici
  • Disphar International B.V.
  • Ciclum Farma Unipessoal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Betahistine Sales Value (2021-2032)
  4. 1.2.2 Global Betahistine Sales Volume (2021-2032)
  5. 1.2.3 Global Betahistine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Betahistine Market Dynamics
  1. 2.1 Betahistine Industry Trends
  2. 2.2 Betahistine Industry Drivers
  3. 2.3 Betahistine Industry Opportunities and Challenges
  4. 2.4 Betahistine Industry Restraints
3 Betahistine Market by Company
  1. 3.1 Global Betahistine Company Revenue Ranking in 2025
  2. 3.2 Global Betahistine Revenue by Company (2021-2026)
  3. 3.3 Global Betahistine Sales Volume by Company (2021-2026)
  4. 3.4 Global Betahistine Average Price by Company (2021-2026)
  5. 3.5 Global Betahistine Company Ranking (2024-2026)
  6. 3.6 Global Betahistine Company Manufacturing Base and Headquarters
  7. 3.7 Global Betahistine Company Product Type and Application
  8. 3.8 Global Betahistine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Betahistine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Betahistine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Betahistine Market by Type
  1. 4.1 Betahistine Type Introduction
  2. 4.1.1 8mg
  3. 4.1.2 25mg
  4. 4.1.3 Others
  5. 4.2 Global Betahistine Sales Volume by Type
  6. 4.2.1 Global Betahistine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Betahistine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Betahistine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Betahistine Sales Value by Type
  10. 4.3.1 Global Betahistine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Betahistine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Betahistine Sales Value Share by Type (2021-2032)
5 Betahistine Market by Application
  1. 5.1 Betahistine Application Introduction
  2. 5.1.1 Cerebral Thrombosis
  3. 5.1.2 Cerebral Embolism
  4. 5.1.3 Others
  5. 5.2 Global Betahistine Sales Volume by Application
  6. 5.2.1 Global Betahistine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Betahistine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Betahistine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Betahistine Sales Value by Application
  10. 5.3.1 Global Betahistine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Betahistine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Betahistine Sales Value Share by Application (2021-2032)
6 Betahistine Regional Sales and Value Analysis
  1. 6.1 Global Betahistine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Betahistine Sales by Region (2021-2032)
  3. 6.2.1 Global Betahistine Sales by Region: 2021-2026
  4. 6.2.2 Global Betahistine Sales by Region (2027-2032)
  5. 6.3 Global Betahistine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Betahistine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Betahistine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Betahistine Sales Value by Region (2027-2032)
  9. 6.5 Global Betahistine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Betahistine Sales Value (2021-2032)
  12. 6.6.2 North America Betahistine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Betahistine Sales Value (2021-2032)
  15. 6.7.2 Europe Betahistine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Betahistine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Betahistine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Betahistine Sales Value (2021-2032)
  21. 6.9.2 South America Betahistine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Betahistine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Betahistine Sales Value Share by Country, 2025 VS 2032
7 Betahistine Country-level Sales and Value Analysis
  1. 7.1 Global Betahistine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Betahistine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Betahistine Sales by Country (2021-2032)
  4. 7.3.1 Global Betahistine Sales by Country (2021-2026)
  5. 7.3.2 Global Betahistine Sales by Country (2027-2032)
  6. 7.4 Global Betahistine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Betahistine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Betahistine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Betahistine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Betahistine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Betahistine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Betahistine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Betahistine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Betahistine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Betahistine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Betahistine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Betahistine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Betahistine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Betahistine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Betahistine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Betahistine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Betahistine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Betahistine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Betahistine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Betahistine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Betahistine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Betahistine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Betahistine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Betahistine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Betahistine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Betahistine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Betahistine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Betahistine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Betahistine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Betahistine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Betahistine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Betahistine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Betahistine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Betahistine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Betahistine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Betahistine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Betahistine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Betahistine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Betahistine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Betahistine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Betahistine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Betahistine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Betahistine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Betahistine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Betahistine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Betahistine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Betahistine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Betahistine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Betahistine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Betahistine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Betahistine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Betahistine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Betahistine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Betahistine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Betahistine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Betahistine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Betahistine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Betahistine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Betahistine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Betahistine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Betahistine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Betahistine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Betahistine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Betahistine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Betahistine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Betahistine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Betahistine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Betahistine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Betahistine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Betahistine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Betahistine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Betahistine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Betahistine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Betahistine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Betahistine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Betahistine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Betahistine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Betahistine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Betahistine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Betahistine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Betahistine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Betahistine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Betahistine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Betahistine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Betahistine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Betahistine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Betahistine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 TOWA PHARMACEUTICAL CO., LTD
  2. 8.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
  3. 8.1.2 TOWA PHARMACEUTICAL CO., LTD Business Overview
  4. 8.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio
  6. 8.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments
  7. 8.2 Takeda Pharmaceutical Company Limited
  8. 8.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 8.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 8.2.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Company Limited Betahistine Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Betahistine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Betahistine Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Orion Corporation
  20. 8.4.1 Orion Corporation Company Information
  21. 8.4.2 Orion Corporation Business Overview
  22. 8.4.3 Orion Corporation Betahistine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Orion Corporation Betahistine Product Portfolio
  24. 8.4.5 Orion Corporation Recent Developments
  25. 8.5 Nichi-Iko Pharmaceutical
  26. 8.5.1 Nichi-Iko Pharmaceutical Company Information
  27. 8.5.2 Nichi-Iko Pharmaceutical Business Overview
  28. 8.5.3 Nichi-Iko Pharmaceutical Betahistine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nichi-Iko Pharmaceutical Betahistine Product Portfolio
  30. 8.5.5 Nichi-Iko Pharmaceutical Recent Developments
  31. 8.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
  32. 8.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
  33. 8.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview
  34. 8.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio
  36. 8.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
  37. 8.7 EA Pharma Co., Ltd.
  38. 8.7.1 EA Pharma Co., Ltd. Company Information
  39. 8.7.2 EA Pharma Co., Ltd. Business Overview
  40. 8.7.3 EA Pharma Co., Ltd. Betahistine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 EA Pharma Co., Ltd. Betahistine Product Portfolio
  42. 8.7.5 EA Pharma Co., Ltd. Recent Developments
  43. 8.8 DOC Generici
  44. 8.8.1 DOC Generici Company Information
  45. 8.8.2 DOC Generici Business Overview
  46. 8.8.3 DOC Generici Betahistine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DOC Generici Betahistine Product Portfolio
  48. 8.8.5 DOC Generici Recent Developments
  49. 8.9 Disphar International B.V.
  50. 8.9.1 Disphar International B.V. Company Information
  51. 8.9.2 Disphar International B.V. Business Overview
  52. 8.9.3 Disphar International B.V. Betahistine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Disphar International B.V. Betahistine Product Portfolio
  54. 8.9.5 Disphar International B.V. Recent Developments
  55. 8.10 Ciclum Farma Unipessoal
  56. 8.10.1 Ciclum Farma Unipessoal Company Information
  57. 8.10.2 Ciclum Farma Unipessoal Business Overview
  58. 8.10.3 Ciclum Farma Unipessoal Betahistine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ciclum Farma Unipessoal Betahistine Product Portfolio
  60. 8.10.5 Ciclum Farma Unipessoal Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Betahistine Value Chain Analysis
  2. 9.1.1 Betahistine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Betahistine Sales Mode & Process
  6. 9.2 Betahistine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Betahistine Distributors
  9. 9.2.3 Betahistine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst